{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "874cf76d",
   "metadata": {},
   "source": [
    "Ollama Connection"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "68170e67",
   "metadata": {},
   "outputs": [],
   "source": [
    "import ollama\n",
    "\n",
    "response = ollama.chat(\n",
    "    model='llama3:latest',\n",
    "    messages=[{\n",
    "        'role': 'user',\n",
    "        'content': 'Reply with exactly this: DIABETAINSIGHT AI ENGINE READY'\n",
    "    }]\n",
    ")\n",
    "print(response['message']['content'])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6bc51bfb",
   "metadata": {},
   "source": [
    "Load Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8870d5d6",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import json\n",
    "import time\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')\n",
    "\n",
    "# Load master data\n",
    "master = pd.read_csv('..Data\\\\Processed\\\\master_health_data.csv')\n",
    "nppa = pd.read_csv('..Data\\\\Processednppa_drug_prices.csv')\n",
    "\n",
    "# Key context numbers for AI\n",
    "total_diabetics = master['Diabetic_Population_Millions'].sum()\n",
    "national_avg_prevalence = master['Diabetes_Prevalence_Pct'].mean()\n",
    "national_avg_income = master['Per_Capita_Income_INR_Thousands'].mean()\n",
    "national_avg_insurance = master['Health_Insurance_Pct'].mean()\n",
    "cheapest_drug = nppa['Monthly_Cost_INR'].min()\n",
    "most_expensive_drug = nppa['Monthly_Cost_INR'].max()\n",
    "\n",
    "print(\"Data loaded\")\n",
    "print(f\"\\nNational Context:\")\n",
    "print(f\"  Total diabetics: {total_diabetics:.1f} million\")\n",
    "print(f\"  Avg prevalence: {national_avg_prevalence:.1f}%\")\n",
    "print(f\"  Avg per capita income: â‚¹{national_avg_income:.0f}K\")\n",
    "print(f\"  Avg insurance coverage: {national_avg_insurance:.1f}%\")\n",
    "print(f\"  Drug cost range: â‚¹{cheapest_drug:.0f} â€“ â‚¹{most_expensive_drug:.0f}/month\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a7e4c5f0",
   "metadata": {},
   "source": [
    "Prompt engine"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "4661dd93",
   "metadata": {},
   "outputs": [],
   "source": [
    "def build_state_prompt(row, national_context):\n",
    "    \n",
    "    prompt = f\"\"\"\n",
    "You are a Senior Commercial Analytics Consultant at a top pharma strategy firm in India.\n",
    "You are analyzing market data for a new Type-2 diabetes drug launching across Indian states.\n",
    "\n",
    "NATIONAL CONTEXT:\n",
    "- Total diabetic population in India: {national_context['total_diabetics']:.1f} million\n",
    "- National average diabetes prevalence: {national_context['avg_prevalence']:.1f}%\n",
    "- National average per capita income: â‚¹{national_context['avg_income']:.0f}K/year\n",
    "- National average health insurance coverage: {national_context['avg_insurance']:.1f}%\n",
    "- First-line drug cost (Metformin): â‚¹{national_context['cheapest_drug']:.0f}/month\n",
    "- Most expensive drug (Insulin): â‚¹{national_context['costliest_drug']:.0f}/month\n",
    "\n",
    "STATE DATA:\n",
    "- State: {row['State']}\n",
    "- Diabetes Prevalence: {row['Diabetes_Prevalence_Pct']}% (national avg: {national_context['avg_prevalence']:.1f}%)\n",
    "- Prediabetes Prevalence: {row['Prediabetes_Prevalence_Pct']}%\n",
    "- Diabetic Population: {row['Diabetic_Population_Millions']:.2f} million\n",
    "- Total At-Risk Population: {row['Total_At_Risk_Millions']:.2f} million\n",
    "- Per Capita Income: â‚¹{row['Per_Capita_Income_INR_Thousands']:.0f}K/year\n",
    "- Health Insurance Coverage: {row.get('Health_Insurance_Pct', 'N/A')}%\n",
    "- High Blood Sugar - Women: {row.get('Women_High_Sugar_Pct', 'N/A')}%\n",
    "- High Blood Sugar - Men: {row.get('Men_High_Sugar_Pct', 'N/A')}%\n",
    "- Overweight - Women: {row.get('Women_Overweight_Pct', 'N/A')}%\n",
    "- Overweight - Men: {row.get('Men_Overweight_Pct', 'N/A')}%\n",
    "- Disease Burden Index: {row['Disease_Burden_Index']:.1f}/100\n",
    "- Commercial Viability Index: {row['Commercial_Viability_Index']:.1f}/100\n",
    "- Opportunity Score: {row['Opportunity_Score']:.1f}/100\n",
    "- Launch Tier: {row['Launch_Tier']}\n",
    "- National Rank: #{int(row['Rank'])} of 30 states\n",
    "\n",
    "YOUR TASK:\n",
    "Analyze this state data and return ONLY a JSON object with exactly these 5 keys.\n",
    "No text before or after. No markdown. No explanation. Just raw JSON.\n",
    "\n",
    "{{\n",
    "  \"market_narrative\": \"2-3 sentences explaining WHY this state has this opportunity score. Use specific numbers. Compare to national averages where relevant.\",\n",
    "  \"strategic_recommendation\": \"2-3 sentences on what the commercial team should specifically DO in this state. Mention timing, focus areas, and channel approach.\",\n",
    "  \"key_risk\": \"1-2 sentences on the single biggest commercial risk in this state.\",\n",
    "  \"prediabetes_opportunity\": \"1 sentence on the prevention market opportunity given the prediabetes prevalence.\",\n",
    "  \"board_summary_line\": \"Exactly one sentence for a CEO board presentation. Must include the opportunity score and one key number.\"\n",
    "}}\n",
    "\"\"\"\n",
    "    return prompt\n",
    "\n",
    "\n",
    "national_context = {\n",
    "    'total_diabetics': total_diabetics,\n",
    "    'avg_prevalence': national_avg_prevalence,\n",
    "    'avg_income': national_avg_income,\n",
    "    'avg_insurance': national_avg_insurance,\n",
    "    'cheapest_drug': cheapest_drug,\n",
    "    'costliest_drug': most_expensive_drug\n",
    "}\n",
    "\n",
    "print(\"Prompt engine ready\")\n",
    "print(f\"Sample prompt size: {len(build_state_prompt(master.iloc[0], national_context))} characters\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9d4f6d4a",
   "metadata": {},
   "source": [
    "The Tamil Nadu test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9cdfa4bd",
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "import json\n",
    "\n",
    "def parse_ai_response(raw_response):\n",
    "    clean = raw_response.strip()\n",
    "    \n",
    "    # Remove markdown code blocks\n",
    "    if '```json' in clean:\n",
    "        clean = clean.split('```json')[1].split('```')[0]\n",
    "    elif '```' in clean:\n",
    "        clean = clean.split('```')[1].split('```')[0]\n",
    "    \n",
    "    # Find JSON boundaries\n",
    "    start = clean.find('{')\n",
    "    end = clean.rfind('}') + 1\n",
    "    if start != -1 and end > start:\n",
    "        clean = clean[start:end]\n",
    "    \n",
    "    # Fix trailing commas\n",
    "    clean = re.sub(r',\\s*}', '}', clean)\n",
    "    clean = re.sub(r',\\s*]', ']', clean)\n",
    "    \n",
    "    try:\n",
    "        return json.loads(clean)\n",
    "    except json.JSONDecodeError:\n",
    "        # Manual extraction â€” handles newlines and periods inside values\n",
    "        result = {}\n",
    "        fields = ['market_narrative', 'strategic_recommendation',\n",
    "                  'key_risk', 'prediabetes_opportunity', 'board_summary_line']\n",
    "        for field in fields:\n",
    "            # This pattern handles periods, commas inside the string value\n",
    "            pattern = rf'\"{field}\"\\s*:\\s*\"((?:[^\"\\\\]|\\\\.)*)\"'\n",
    "            match = re.search(pattern, clean, re.DOTALL)\n",
    "            if match:\n",
    "                result[field] = match.group(1).strip()\n",
    "            else:\n",
    "                result[field] = 'Analysis unavailable'\n",
    "        return result\n",
    "\n",
    "# Verify on Tamil Nadu first\n",
    "parsed = parse_ai_response(raw)\n",
    "print(\"Parser test on Tamil Nadu:\\n\")\n",
    "for key, value in parsed.items():\n",
    "    print(f\"{key}:\\n{value}\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "51bd58a9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ğŸš€ Starting AI analysis for all 30 states...\n",
      "â±ï¸  Estimated time: 8â€“12 minutes\n",
      "\n",
      "============================================================\n",
      "[01/30] Andhra Pradesh         (Rank #04)... âœ…\n",
      "[02/30] Arunachal Pradesh      (Rank #29)... âœ…\n",
      "[03/30] Assam                  (Rank #21)... âœ…\n",
      "[04/30] Bihar                  (Rank #28)... âœ…\n",
      "[05/30] Chhattisgarh           (Rank #25)... âœ…\n",
      "[06/30] Goa                    (Rank #02)... âœ…\n",
      "[07/30] Gujarat                (Rank #10)... âœ…\n",
      "[08/30] Haryana                (Rank #13)... âœ…\n",
      "[09/30] Himachal Pradesh       (Rank #16)... âœ…\n",
      "[10/30] Jharkhand              (Rank #27)... âœ…\n",
      "[11/30] Karnataka              (Rank #06)... âœ…\n",
      "[12/30] Kerala                 (Rank #03)... âœ…\n",
      "[13/30] Madhya Pradesh         (Rank #24)... âœ…\n",
      "[14/30] Maharashtra            (Rank #08)... âœ…\n",
      "[15/30] Manipur                (Rank #23)... âœ…\n",
      "[16/30] Meghalaya              (Rank #26)... âœ…\n",
      "[17/30] Mizoram                (Rank #17)... âœ…\n",
      "[18/30] Nagaland               (Rank #30)... âœ…\n",
      "[19/30] Odisha                 (Rank #19)... âœ…\n",
      "[20/30] Punjab                 (Rank #09)... âœ…\n",
      "[21/30] Rajasthan              (Rank #18)... âœ…\n",
      "[22/30] Sikkim                 (Rank #12)... âœ…\n",
      "[23/30] Tamil Nadu             (Rank #01)... âœ…\n",
      "[24/30] Telangana              (Rank #07)... âœ…\n",
      "[25/30] Tripura                (Rank #20)... âœ…\n",
      "[26/30] Uttar Pradesh          (Rank #15)... âœ…\n",
      "[27/30] Uttarakhand            (Rank #14)... âœ…\n",
      "[28/30] West Bengal            (Rank #11)... âœ…\n",
      "[29/30] Delhi                  (Rank #05)... âœ…\n",
      "[30/30] Jammu & Kashmir        (Rank #22)... âœ…\n",
      "\n",
      "============================================================\n",
      "âœ… Complete: 30/30 states processed\n"
     ]
    }
   ],
   "source": [
    "results = []\n",
    "total_states = len(master)\n",
    "\n",
    "print(f\"ğŸš€ Starting AI analysis for all {total_states} states...\")\n",
    "\n",
    "print(\"=\"*60)\n",
    "\n",
    "for idx, row in master.iterrows():\n",
    "    state_name = row['State']\n",
    "    rank = int(row['Rank'])\n",
    "    \n",
    "    print(f\"[{idx+1:02d}/{total_states}] {state_name:<22} (Rank #{rank:02d})...\",\n",
    "          end=' ', flush=True)\n",
    "    \n",
    "    try:\n",
    "        prompt = build_state_prompt(row, national_context)\n",
    "        \n",
    "        response = ollama.chat(\n",
    "            model='llama3:latest',\n",
    "            messages=[{'role': 'user', 'content': prompt}],\n",
    "            options={'temperature': 0.3, 'num_predict': 800}\n",
    "        )\n",
    "        \n",
    "        parsed = parse_ai_response(response['message']['content'])\n",
    "        parsed['State'] = state_name\n",
    "        parsed['Opportunity_Score'] = row['Opportunity_Score']\n",
    "        parsed['Launch_Tier'] = row['Launch_Tier']\n",
    "        parsed['Rank'] = rank\n",
    "        \n",
    "        results.append(parsed)\n",
    "        print(\"âœ…\")\n",
    "        time.sleep(1)\n",
    "        \n",
    "    except Exception as e:\n",
    "        print(f\"âŒ {e}\")\n",
    "        results.append({\n",
    "            'State': state_name,\n",
    "            'Opportunity_Score': row['Opportunity_Score'],\n",
    "            'Launch_Tier': row['Launch_Tier'],\n",
    "            'Rank': rank,\n",
    "            'market_narrative': 'Error during analysis',\n",
    "            'strategic_recommendation': 'Rerun required',\n",
    "            'key_risk': 'Processing error',\n",
    "            'prediabetes_opportunity': 'N/A',\n",
    "            'board_summary_line': 'Analysis incomplete'\n",
    "        })\n",
    "\n",
    "print(\"\\n\" + \"=\"*60)\n",
    "print(f\"Complete: {len(results)}/{total_states} states processed\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "775b1667",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saved: data/processed/ai_insights_complete.csv\n",
      "Shape: (30, 36)\n",
      "\n",
      "======================================================================\n",
      "   AI-GENERATED INSIGHTS â€” PRIORITY STATES\n",
      "======================================================================\n",
      "\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "#1 TAMIL NADU | Score: 78.7 | Tier 1 â€” Launch Immediately\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "ğŸ“Š Tamil Nadu's high diabetes prevalence (26.3%) and large diabetic population (20.46 million) create a significant market opportunity, driven by the state's higher per capita income (â‚¹172K/year) and health insurance coverage (66.5%). This is 2x the national average of 12.6% and 1.5x the national average of â‚¹158K/year.\n",
      "ğŸ¯ Launch the new Type-2 diabetes drug immediately, focusing on Tier 1 cities with high-potential HCPs and a channel approach prioritizing digital marketing to reach the large at-risk population (34.78 million).\n",
      "âš ï¸  The single biggest commercial risk is the potential competition from existing glucose-lowering therapies, particularly Metformin, which is widely prescribed and relatively affordable (â‚¹91/month).\n",
      "ğŸ“‹ Tamil Nadu offers a 78.7/100 opportunity score, driven by its large diabetic population and higher per capita income, making it an attractive launch state for our new Type-2 diabetes drug.\n",
      "\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "#2 GOA | Score: 63.4 | Tier 1 â€” Launch Immediately\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "ğŸ“Š Goa's high diabetes prevalence (20.1%) and prediabetes prevalence (14.2%) create a significant opportunity, driven by women's higher risk of developing high blood sugar (20.8%). This is 65% higher than the national average, indicating a strong need for effective treatment options.\n",
      "ğŸ¯ Launch immediately in Goa, focusing on Tier-1 cities and leveraging health insurance coverage (66%) to drive adoption, while also targeting women's health initiatives to capitalize on their increased risk.\n",
      "âš ï¸  The single biggest commercial risk is the high cost of insulin therapy, which may deter patients from adopting treatment options, especially with the average per capita income in Goa being â‚¹516K/year.\n",
      "ğŸ“‹ Goa presents an attractive opportunity with an Opportunity Score of 63.4/100, driven by its high diabetes prevalence; we recommend launching immediately to capitalize on this potential.\n",
      "\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "#3 KERALA | Score: 59.8 | Tier 2 â€” Launch in 6 Months\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "ğŸ“Š Kerala's high diabetes prevalence (19.4%) and large diabetic population (6.81 million) create a significant market opportunity, driven by the state's relatively higher per capita income (â‚¹204K/year). This is reflected in the Opportunity Score of 59.8/100.\n",
      "ğŸ¯ The commercial team should prioritize launching in Tier 2 cities within six months, focusing on digital marketing and leveraging health insurance coverage (51.5%) to target high-value patients.\n",
      "âš ï¸  The biggest commercial risk is the potential for price sensitivity among patients, particularly given the relatively low cost of first-line drugs like Metformin (â‚¹91/month).\n",
      "ğŸ“‹ Kerala offers an Opportunity Score of 59.8/100, driven by its large diabetic population and relatively higher per capita income, making it an attractive launch market.\n",
      "\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "#4 ANDHRA PRADESH | Score: 55.3 | Tier 2 â€” Launch in 6 Months\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "ğŸ“Š Andhra Pradesh's high diabetes prevalence (16.8%) and large diabetic population (8.77 million) create a significant market opportunity, driven by the state's higher per capita income (â‚¹172K/year) and health insurance coverage (70.2%). Compared to the national average of 12.6%, Andhra Pradesh has a notable gap in diabetes management.\n",
      "ğŸ¯ The commercial team should focus on Tier 2 cities, targeting high-income groups with targeted marketing campaigns, leveraging digital channels, and partnering with local healthcare providers to drive early adoption.\n",
      "âš ï¸  The single biggest commercial risk is the competition from established players in the market, particularly in the insulin segment, which may lead to pricing pressure and erosion of market share.\n",
      "ğŸ“‹ Andhra Pradesh offers an Opportunity Score of 55.3/100, driven by its large diabetic population, with a key focus on Tier 2 cities to drive early adoption and capitalize on the state's higher per capita income.\n",
      "\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "#5 DELHI | Score: 49.5 | Tier 2 â€” Launch in 6 Months\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "ğŸ“Š Delhi's high diabetes prevalence (18.6%) and large diabetic population (5.97 million) create a significant market opportunity, driven by the state's relatively high per capita income (â‚¹389K/year). Compared to the national average of 12.6%, Delhi's prevalence is almost 50% higher, indicating a strong demand for effective diabetes management solutions.\n",
      "ğŸ¯ The commercial team should focus on targeting urban areas with high-income households, leveraging digital channels and partnerships with primary care physicians to drive awareness and adoption within the next 6 months.\n",
      "âš ï¸  The biggest commercial risk in Delhi is the potential for competition from established players and generic alternatives, which could erode market share if not addressed proactively.\n",
      "ğŸ“‹ Delhi offers an attractive opportunity score of 49.5/100, driven by its large diabetic population and relatively high per capita income, making it an ideal launch market within the next 6 months.\n",
      "\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "#6 KARNATAKA | Score: 47.6 | Tier 2 â€” Launch in 6 Months\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "ğŸ“Š Karnataka's high diabetes prevalence (17.8%) and large diabetic population (12.02 million) create a significant market opportunity, driven by the state's relatively higher per capita income (â‚¹231K/year). This is particularly notable given the national average of 12.6%.\n",
      "ğŸ¯ Focus on Tier-2 cities with high diabetes prevalence and launch in 6 months to capitalize on the market momentum. Utilize a multi-channel approach, including digital marketing and healthcare professional engagement.\n",
      "âš ï¸  The single biggest commercial risk is the high competition from established players in the metformin segment, which could lead to price pressure and erosion of market share.\n",
      "ğŸ“‹ Karnataka offers an attractive commercial opportunity with an Opportunity Score of 47.6/100, driven by its large diabetic population and relatively higher per capita income.\n",
      "\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "#7 TELANGANA | Score: 46.9 | Tier 2 â€” Launch in 6 Months\n",
      "â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
      "ğŸ“Š Telangana's higher diabetes prevalence (15.9%) and larger diabetic population (5.96 million) compared to national averages create a significant market opportunity. The state's relatively high per capita income (â‚¹228K/year) and good health insurance coverage (60.8%) also contribute to this score.\n",
      "ğŸ¯ The commercial team should focus on Tier-2 cities, targeting the large diabetic population with targeted marketing campaigns starting six months prior to launch, leveraging digital channels and partnerships with local healthcare providers.\n",
      "âš ï¸  The biggest risk is the high competition from established players in the market, particularly in the insulin segment, which may lead to pricing pressure and slower adoption of the new drug.\n",
      "ğŸ“‹ Telangana offers an attractive commercial opportunity with an Opportunity Score of 46.9/100, driven by its large diabetic population and relatively high per capita income.\n"
     ]
    }
   ],
   "source": [
    "insights_df = pd.DataFrame(results)\n",
    "\n",
    "# Merge with master\n",
    "final_df = master.merge(\n",
    "    insights_df[['State', 'market_narrative', 'strategic_recommendation',\n",
    "                 'key_risk', 'prediabetes_opportunity', 'board_summary_line']],\n",
    "    on='State', how='left'\n",
    ")\n",
    "\n",
    "final_df.to_csv('..Data\\\\Processed\\\\ai_insights_complete.csv', index=False)\n",
    "print(\"Saved: data/processed/ai_insights_complete.csv\")\n",
    "print(f\"Shape: {final_df.shape}\")\n",
    "\n",
    "# Preview Tier 1 + 2 insights\n",
    "priority = final_df[final_df['Launch_Tier'].isin([\n",
    "    'Tier 1 â€” Launch Immediately',\n",
    "    'Tier 2 â€” Launch in 6 Months'\n",
    "])].sort_values('Rank')\n",
    "\n",
    "print(\"\\n\" + \"=\"*70)\n",
    "print(\"   AI-GENERATED INSIGHTS â€” PRIORITY STATES\")\n",
    "print(\"=\"*70)\n",
    "\n",
    "for _, row in priority.iterrows():\n",
    "    print(f\"\\n{'â”€'*70}\")\n",
    "    print(f\"#{row['Rank']} {row['State'].upper()} | \"\n",
    "          f\"Score: {row['Opportunity_Score']:.1f} | {row['Launch_Tier']}\")\n",
    "    print(f\"{'â”€'*70}\")\n",
    "    print(f\"ğŸ“Š {row['market_narrative']}\")\n",
    "    print(f\"ğŸ¯ {row['strategic_recommendation']}\")\n",
    "    print(f\"âš ï¸  {row['key_risk']}\")\n",
    "    print(f\"ğŸ“‹ {row['board_summary_line']}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ccc9c821",
   "metadata": {},
   "source": [
    "RESULT SUMMARY"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "68800f5f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ğŸ¤– Generating Executive Summary...\n",
      "\n",
      "======================================================================\n",
      "        DIABETAINSIGHT â€” AI EXECUTIVE SUMMARY\n",
      "======================================================================\n",
      "As the Executive Summary for DiabetaInsight, I am pleased to present the findings of our AI-powered market entry analysis for a new Type-2 diabetes drug launching in India. The scale of India's diabetes crisis is staggering, with a national average prevalence rate of 12.6% and a total diabetic population of 165.8 million. This presents a significant commercial opportunity for pharmaceutical companies looking to enter the Indian market.\n",
      "\n",
      "Our methodology involved leveraging a range of data sources, including ICMR-INDIAB 2023 (Lancet), NFHS-5 (MoHFW GoI), NPPA Drug Prices June 2025, and RBI State Income Data. We utilized Llama 3, an AI engine deployed via Ollama, to analyze the data and generate an opportunity score for each of India's 30 states. This score takes into account both the disease burden and commercial viability in each state.\n",
      "\n",
      "Our key findings reveal that Tamil Nadu ranks #1 with an opportunity score of 78.67, driven by a high disease burden and commercial viability. Goa, despite having only 1.5 million people, ranks #2 with an opportunity score of 63.44, thanks to its high per capita income. Maharashtra, India's financial capital, ranks #8 with a moderate disease burden and commercial viability. On the other hand, Uttar Pradesh, despite having a large population, ranks #15 due to a high disease burden but low commercial viability.\n",
      "\n",
      "Based on our findings, we recommend that the commercial team prioritize launching in Tamil Nadu and Goa immediately, followed by Andhra Pradesh, Karnataka, Kerala, Telangana, and Delhi within six months. We also suggest monitoring Gujarat, Haryana, Maharashtra, Punjab, Sikkim, Uttar Pradesh, Uttarakhand, and West Bengal for potential future opportunities. Finally, we advise deprioritizing the remaining 15 states due to low commercial viability or disease burden. By focusing on these key markets, our client can maximize its return on investment and effectively enter the Indian diabetes market.\n",
      "\n",
      "Executive summary saved\n"
     ]
    }
   ],
   "source": [
    "tier1 = final_df[final_df['Launch_Tier']=='Tier 1 â€” Launch Immediately']\n",
    "tier2 = final_df[final_df['Launch_Tier']=='Tier 2 â€” Launch in 6 Months']\n",
    "tier3 = final_df[final_df['Launch_Tier']=='Tier 3 â€” Monitor']\n",
    "tier4 = final_df[final_df['Launch_Tier']=='Tier 4 â€” Deprioritize']\n",
    "\n",
    "exec_prompt = f\"\"\"\n",
    "You are writing the Executive Summary for a pharma commercial strategy report\n",
    "called DiabetaInsight â€” an AI-powered market entry analysis for a new Type-2\n",
    "diabetes drug launching in India.\n",
    "\n",
    "PROJECT CONTEXT:\n",
    "- Built by: Siddhant Ranjan, PGDM Business Analytics & Marketing\n",
    "- Data sources: ICMR-INDIAB 2023 (Lancet), NFHS-5 (MoHFW GoI), \n",
    "  NPPA Drug Prices June 2025, RBI State Income Data\n",
    "- AI engine: Llama 3 (local deployment via Ollama)\n",
    "- States analyzed: 30\n",
    "\n",
    "KEY NUMBERS:\n",
    "- Total Indian diabetic population: {total_diabetics:.1f} million\n",
    "- National average diabetes prevalence: {national_avg_prevalence:.1f}%\n",
    "- First-line drug cost: â‚¹{cheapest_drug:.0f}/month (Metformin)\n",
    "- Most expensive drug: â‚¹{most_expensive_drug:.0f}/month (Insulin)\n",
    "\n",
    "TIER 1 â€” LAUNCH IMMEDIATELY ({len(tier1)} states):\n",
    "{tier1[['State','Opportunity_Score','Diabetic_Population_Millions']].to_string(index=False)}\n",
    "Combined diabetic population: {tier1['Diabetic_Population_Millions'].sum():.1f} million\n",
    "\n",
    "TIER 2 â€” LAUNCH IN 6 MONTHS ({len(tier2)} states):\n",
    "{tier2[['State','Opportunity_Score','Diabetic_Population_Millions']].to_string(index=False)}\n",
    "Combined diabetic population: {tier2['Diabetic_Population_Millions'].sum():.1f} million\n",
    "\n",
    "TIER 3 â€” MONITOR ({len(tier3)} states):\n",
    "{tier3[['State','Opportunity_Score']].to_string(index=False)}\n",
    "\n",
    "TIER 4 â€” DEPRIORITIZE ({len(tier4)} states):\n",
    "{tier4[['State','Opportunity_Score']].to_string(index=False)}\n",
    "\n",
    "KEY STRATEGIC FINDINGS:\n",
    "1. Tamil Nadu ranks #1 (78.7/100) â€” highest disease burden AND commercial viability combined\n",
    "2. Goa ranks #2 (63.4) despite only 1.5M population â€” highest per capita income in India\n",
    "3. Maharashtra ranks #8 despite being India's financial capital â€” moderate burden + moderate viability\n",
    "4. Uttar Pradesh ranks #15 despite 231M population â€” high disease burden, low commercial viability\n",
    "5. Rajasthan anomaly: high commercial viability (44.6) but low disease burden (12.7) â€” prevention market\n",
    "\n",
    "TASK:\n",
    "Write a formal Executive Summary in exactly 4 paragraphs:\n",
    "\n",
    "Paragraph 1: The scale of India's diabetes crisis and why this analysis was needed.\n",
    "Paragraph 2: Methodology â€” what data was used and how the opportunity score was built.\n",
    "Paragraph 3: Key findings â€” specific states, specific numbers, the surprising insights.\n",
    "Paragraph 4: Strategic recommendations and call to action for the commercial team.\n",
    "\n",
    "Rules:\n",
    "- Formal consulting language\n",
    "- Every paragraph must contain specific numbers\n",
    "- No bullet points â€” flowing prose only\n",
    "- 280-320 words total\n",
    "- End with a clear business recommendation\n",
    "\"\"\"\n",
    "\n",
    "print(\"ğŸ¤– Generating Executive Summary...\\n\")\n",
    "\n",
    "exec_response = ollama.chat(\n",
    "    model='llama3:latest',\n",
    "    messages=[{'role': 'user', 'content': exec_prompt}],\n",
    "    options={'temperature': 0.4, 'num_predict': 1500}\n",
    ")\n",
    "\n",
    "executive_summary = exec_response['message']['content']\n",
    "\n",
    "print(\"=\"*70)\n",
    "print(\"        DIABETAINSIGHT â€” AI EXECUTIVE SUMMARY\")\n",
    "print(\"=\"*70)\n",
    "print(executive_summary)\n",
    "\n",
    "# Save\n",
    "with open('..Data\\\\Processed\\\\executive_summary.txt', 'w', encoding='utf-8') as f:\n",
    "    f.write(\"DIABETAINSIGHT\\n\")\n",
    "    f.write(\"Pharma Commercial Intelligence System â€” India Diabetes Market\\n\")\n",
    "    f.write(\"=\"*70 + \"\\n\\n\")\n",
    "    f.write(\"EXECUTIVE SUMMARY\\n\\n\")\n",
    "    f.write(executive_summary)\n",
    "    f.write(\"\\n\\n\" + \"=\"*70)\n",
    "    f.write(\"\\nData Sources: ICMR-INDIAB 2023 | NFHS-5 | NPPA June 2025 | RBI\")\n",
    "    f.write(\"\\nAI Engine: Llama 3 (local) | Built by: Siddhant Ranjan\")\n",
    "\n",
    "print(\"\\nExecutive summary saved\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
